We are live on ! Find out more
PALI icon

Palisade Bio

6 hedge funds and large institutions have $235K invested in Palisade Bio in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

14% less funds holding

Funds holding: 76 (-1)

49% less capital invested

Capital invested by funds: $463K → $235K (-$227K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less call options, than puts

Call options by funds: $1K | Put options by funds: $4K

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
2
Calls
$1K
Puts
$4K
Net Calls
-$3K
Net Calls Change
-$5K

PALI Hedge Fund Activity: Q2 2019 in Review

6 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2019, worth a combined $235K — down 49% from $463K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PALI and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $77.6K. The largest seller was Sabby Management, exiting entirely with an estimated $106K sold.

  • 6 institutional investors held Palisade Bio (PALI) as of Q2 2019, down from 7 in Q1 2019.
  • Funds reported $235K of Palisade Bio stock for Q2 2019, down 49% quarter-over-quarter.
  • 1 fund opened new Palisade Bio positions in Q2 2019 and 2 closed out, a net change of -1 holder.
  • The largest Palisade Bio buyer in Q2 2019 was Renaissance Technologies, an estimated $77.6K added.
  • The largest Palisade Bio seller in Q2 2019 was Sabby Management, an estimated $106K sold.

Based on aggregated 13F filings for Q2 2019.